Australia Opioid Use Disorder Drug Market (2025-2031) | Share, Growth, Companies, Segmentation, Outlook, Trends, Forecast, Industry, Value, Size & Revenue, Analysis, Competitive Landscape

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Australia Country Macro Economic Indicators

3.2 Australia Opioid Use Disorder Drug Market Revenues & Volume, 2021 & 2031F

3.3 Australia Opioid Use Disorder Drug Market - Industry Life Cycle

3.4 Australia Opioid Use Disorder Drug Market - Porter's Five Forces

3.5 Australia Opioid Use Disorder Drug Market Revenues & Volume Share, By Buprenorphine, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of opioid use disorder in Australia

4.2.2 Government initiatives and funding to address opioid addiction

4.2.3 Growing awareness and acceptance of medication-assisted treatment for opioid use disorder

4.3 Market Restraints

4.3.1 Stringent regulations and policies surrounding opioid prescribing and dispensing

4.3.2 Stigma associated with opioid use disorder leading to underreporting and undertreatment

6.1 Australia Opioid Use Disorder Drug Market, By Buprenorphine

6.1.1 Overview and Analysis

6.1.2 Australia Opioid Use Disorder Drug Market Revenues & Volume, By Buprenorphine, 2021- 2031F

6.1.3 Australia Opioid Use Disorder Drug Market Revenues & Volume, By Methadone, 2021- 2031F

6.1.4 Australia Opioid Use Disorder Drug Market Revenues & Volume, By Naltrexone, 2021- 2031F

7.1 Australia Opioid Use Disorder Drug Market Export to Major Countries

7.2 Australia Opioid Use Disorder Drug Market Imports from Major Countries

8.1 Number of individuals accessing opioid use disorder treatment programs

8.2 Rate of successful completion of opioid addiction treatment programs

8.3 Percentage of healthcare professionals trained in opioid addiction management and treatment

8.4 Adoption rate of evidence-based practices for opioid use disorder treatment

8.5 Patient satisfaction and retention rates in opioid addiction treatment programs

9.1 Australia Opioid Use Disorder Drug Market Opportunity Assessment, By Buprenorphine, 2021 & 2031F

10.1 Australia Opioid Use Disorder Drug Market Revenue Share, By Companies, 2024

10.2 Australia Opioid Use Disorder Drug Market Competitive Benchmarking, By Operating and Technical Parameters